Used in neuroscience and biomedical research to quantitatively measure dopamine levels in biological samples such as cell cultures, brain tissue homogenates, cerebrospinal fluid, and serum. Enables researchers to study dopamine-related pathways and disorders including Parkinson’s disease, schizophrenia, addiction, and depression. Supports high-throughput screening in drug development for evaluating the impact of therapeutic compounds on dopamine release and metabolism. Provides a reliable, sensitive, and specific method for detecting low concentrations of dopamine, facilitating accurate data collection in experimental models and clinical studies.